HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Preparation and patient education prior to colonoscopy
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Needleless connectors for intravenous injections
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Pathways for management of alcohol withdrawal in critical care units
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Non-pharmacologic strategies for the management of inpatient aggressive behavior
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Hypertension in patients undergoing carotid endarterectomy
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Patient lifestyle education for lung transplant recipients
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Heparin flush for central and peripheral venous access devices
2017	Penn Medicine Center for Evidence-based Practice (CEP)	High-dose Vitamin C for treatment of sepsis
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Peer specialists in crisis response centers
2017	Penn Medicine Center for Evidence-based Practice (CEP)	APSO vs. SOAP structure for progress notes
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Oral antibiotics for secondary prophylaxis following two-stage revision surgery for prosthetic joint infection
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Association of hats with risk of SIDS in newborns
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Family presence during resuscitation
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Productivity and access measures for primary care
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Intravenous iron for patients with anemia
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Mortality review
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Pre-procedural fasting for inpatients undergoing interventional radiology or cardiac procedures not requiring general anesthesia
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Evaluation and management of post-discharge fever in prosthetic joint replacement patients
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Support for 'second victims' in the acute care setting
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Protocols for discontinuing the use of 1:1 patient sitters in the acute care setting
2017	Penn Medicine Center for Evidence-based Practice (CEP)	Epidemiology of spectator injuries at baseball games
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous aortic valve replacement (TAVI) in Austria. Part 2: Data analysis]
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Social return on investment: outcomes, methods, and economic parameters
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Nivolumab (Opdivo®) for metastatic DNA mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer (CRC)
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Durvalumab (Imfinzi™) for the treatment of patients with stage III non-small-cell lung cancer after prior chemoradiotherapy
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Perinatal care at the threshold of viability; Part I: Systematic analysis of outcomes and resource needs for neonatal intensive care units to inform healthcare planning
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs)
2017	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Psychotherapy - concepts, effect factors and a comparison of legal regulations in three German speaking countries]
2017	Institute of Health Economics (IHE)	Community paramedicine: program characteristics and evaluation
2017	Andalusian Health Technology Assessment Area (AETSA)	Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2017	Andalusian Health Technology Assessment Area (AETSA)	Assessment of efficacy, effectiveness and safety of transcranial doppler ultrasonography in acute ischaemic stroke
2017	Andalusian Health Technology Assessment Area (AETSA)	CMV-specific T-cell immunity in kidney transplantation. Monitoring the CMV-specific T-cell response: pre and post-transplant
2017	Andalusian Health Technology Assessment Area (AETSA)	Hip arthroscopy. Appropriateness criteria
2017	Andalusian Health Technology Assessment Area (AETSA)	Utility of pulmonary metastases resection for colorectal cancer
2017	Andalusian Health Technology Assessment Area (AETSA)	Non invasive fetal lung maturity test
2017	Andalusian Health Technology Assessment Area (AETSA)	Intra-abdominal vagal nerve blockade and malabsortive devices for severe obesity.
2017	Andalusian Health Technology Assessment Area (AETSA)	Hip arthroplasty in patients with osteoarthritis
2017	Andalusian Health Technology Assessment Area (AETSA)	Direct acting antivirals for the chronic hepatitis C infection. Relative assessment of efficacy and safety. Executive summary
2017	Andalusian Health Technology Assessment Area (AETSA)	Multitarget stool DNA testing for colorectal cancer screening.
2017	Health Sciences Institute in Aragon (IACS)	Motorised assistive walking device in patients with muscle weakness in the lower limbs
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Effectiveness of non-invasive mechanical ventilation for the treatment of respiratory failure in patients with amyotrophic lateral sclerosis]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Online hemodiafiltration: evaluation of its safety, effectiveness, cost and usage indications]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (EMD) in superficial gastrointestinal tumors]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis of the efficacy, safety and efficiency of stabilisation of intervertebral discs using Discogel]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve (MitraClip). Monitoring Study Protocol (1st part)]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve using a Clip. Monitoring study (part 2)]
2017	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with HPV vaccination
2017	Adelaide Health Technology Assessment (AHTA)	Prosigna (PAM50) for predicting breast cancer recurrence
2017	Adelaide Health Technology Assessment (AHTA)	Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility
2017	Adelaide Health Technology Assessment (AHTA)	Magnetic Resonance Imaging of patients with suspected non-ischaemic cardiomyopathies
2017	Adelaide Health Technology Assessment (AHTA)	Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2017	Adelaide Health Technology Assessment (AHTA)	Assessment of extended half-life clotting factor concentrates
2017	Adelaide Health Technology Assessment (AHTA)	Substitution of 68-Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369
2017	Norwegian Institute of Public Health (NIPH)	Assessment of conductive education for children and adolescents with brain damage: a health technology assessment
2017	Norwegian Institute of Public Health (NIPH)	Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening
2017	Norwegian Institute of Public Health (NIPH)	Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017	Norwegian Institute of Public Health (NIPH)	FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment
2017	Norwegian Institute of Public Health (NIPH)	Assessment of four intensive habilitation programs for children and adolescents with brain damage – a health technology assessment
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: statins, lipid-lowering agents and cardiovascular risk reduction]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guideline about breastfeeding]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Guide for breastfeeding mother. Guide for women who wish to breastfeed or who breastfeed, as well as their partners and family]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Guide on Prader-Willi Syndrome. Guide to health personnel for the adequate knowledge and management of a rare disease called Prader-Willi Syndrome]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: beta-lactam allergies, assessment of the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge in support of the decision to integrate new endobronchial ultrasound (EBUS) services in Québec hospitals]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: fibrinolysis in ST-segment elevation acute myocardial infarction]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal usage guide: cellulitis in adults and children]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: maintaining a stockpile of influenza antivirals in preparation for a flu pandemic]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: update of proton radiation therapy indications in oncology]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portraits describing pharmacological and non-pharmacological interventions for attention deficit hyperactivity disorder (ADHD) in Quebecers 25 years of age and under]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report on optimal antipsychotic use and the nonpharmacological management of the behavioural and psychological symptoms of dementia in people with major neurocognitive disorders living in residential and long-term care centers]
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report and optimal usage guide: immunoglobulins in neurology]
2017	European Network for Health Technology Assessment (EUnetHTA)	Midostaurin with standard chemotherapy in FLT3-positive acute myeloid leukaemia
2017	European Network for Health Technology Assessment (EUnetHTA)	Antibacterial-coated sutures versus non-antibacterial-coated sutures for the prevention of abdominal, superficial and deep incisional, surgical site infection (SSI)
2017	European Network for Health Technology Assessment (EUnetHTA)	Repetitive transcranial magnetic stimulation for treatment-resistant major depression
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dabrafenib plus trametinib for advanced melanoma]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dipeptidyl peptidase-4 inhibitors as treatment for diabetes mellitus]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiazolidinediones for the treatment of type 2 diabetes mellitus]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Preoperative virtual planning assisted surgery]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Posaconazole for invasive fungal infection treatment and prevention in neutropenic patients]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bilateral cochlear implants in hearing loss]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Platelet-rich plasma in fractures and bone pseudoarthrosis]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Efavirenz, Emtricitabine and Tenofovir (Simplir®) in HIV infection – comparison with other brands in Argentina]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Alprostadil for nonrevascularizable critical lower limb ischemia]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Atazanavir/cobicistat (Evotaz®) in HIV infection]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deferred parathyroid autograft with cryopreserved tissue for the surgical management of hyperparathyroidism]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dolutegravir, Abacavir and Lamivudine (Triumeq®) in HIV infection]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Rituximab biosimilars]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nintedanib (Ofev®) in the treatment of idiopathic pulmonary fibrosis]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Matrix-assisted laser desorption/ionization-time of flight analyzer (MALDI-TOF) in infections]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Single-donor platelet concentrate in patients with thrombocytopenia]